During the past decade, Centro Medico Privado de Reumatologia conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 33 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 25 clinical trials were completed. i.e. 277.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Medico Privado de Reumatologia" #1 sponsor was "Eli Lilly and Company" with 9 trials, followed by "Pfizer" with 8 trials sponsored, "Galapagos NV" with 4 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored and "EMD Serono" with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Medico Privado de Reumatologia" #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Centro Medico Privado de Reumatologia" are "Rheumatoid Arthritis" (14 trials), "Lupus Erythematosus, Systemic" (9 trials), "Systemic Lupus Erythematosus" (6 trials), "Juvenile Idiopathic Arthritis" (3 trials) and "Psoriatic Arthritis" (3 trials). Many other conditions were trialed in "Centro Medico Privado de Reumatologia" in a lesser frequency.

Most popular intervention types in "Centro Medico Privado de Reumatologia" are "Drug" (45 trials), "Biological" (7 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Atacicept 150 mg" (3 trials), "Baricitinib" (3 trials), "Abatacept" (2 trials) and "Atacicept 75 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centro Medico Privado de Reumatologia" are 48 trials for "All" genders.

Currently, there are NaN active trials in "Centro Medico Privado de Reumatologia". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 27 completed trials in Centro Medico Privado de Reumatologia, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Medico Privado de Reumatologia, 1 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".